Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) Return on Sales (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Return on Sales for 5 consecutive years, with 85.23% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 1931.0% to 85.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 85.23% through Dec 2025, down 1931.0% year-over-year, with the annual reading at 14.55% for FY2023, N/A changed from the prior year.
  • Return on Sales hit 85.23% in Q4 2025 for Kezar Life Sciences, down from 94.25% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 129.73% in Q4 2022 to a low of 16.31% in Q4 2023.
  • Historically, Return on Sales has averaged 67.27% across 5 years, with a median of 63.09% in 2022.
  • Biggest five-year swings in Return on Sales: tumbled -14604bps in 2023 and later surged 12287bps in 2024.
  • Year by year, Return on Sales stood at 89.38% in 2021, then skyrocketed by 45bps to 129.73% in 2022, then tumbled by -113bps to 16.31% in 2023, then skyrocketed by 741bps to 104.54% in 2024, then decreased by -18bps to 85.23% in 2025.
  • Business Quant data shows Return on Sales for KZR at 85.23% in Q4 2025, 94.25% in Q3 2025, and 45.38% in Q2 2025.